No way, Medivolve share prices stay at these levels Medivolve should stop buying other businesses and issuing shares for them. Good, they cancelled the Karland Health buying deal and they should also cancel the Noble Bioscience deal. As Medivolve share price should go up with the awareness campaign. These people can turn around and flood the market by selling all these free shares.
Medivolve should hold off issuing any new shares until the next 2-3 months. I think by end of the March or early April BloFish trial should be completed and submitted for EUA. By April 200 plus, collection sites should be installed generating $50 million-plus revenue per month. Year-end finances are released at the end of April. Medivolve brand awareness campaign at full speed by April. Medivolve should be trading in Dollars, not cents. At that point, Medivolve can make any needed business acquisitions. Medivolve can buy these businesses by issuing 2 million shares instead of 20 million shares. For now, fewer outstanding shares can calculate into the higher stock price.
Medivolve just hired 3 marketing companies to build collection sites brand and awareness campaign for Medivolve in the investment community. No way, Medivolve share prices stay at these levels for long. I don't think Medivolve spending this much money to get MEDV a few cents higher. All Medivolve needs is to attract people who know how to see forward-looking revenue, calculate EBTIDA margin and use PE ratio.
Medivolve revenue was about $11.6 million in January with 32 collection sites. Future revenue should increase with 62 collection sites in February, 107 in March. The next phase is adding another 70 collection sites starting in early March. https://medivolve.ca/investor-presentation/
If anyone doubts Medivolve future trading into $4-5 dollars then find me a company with this kind of revenue and trading under $100 million market cap. This does not include revenue from SANATY IPS Columbia 28% owned by Medivolve. https://www.facebook.com/ipssanaty Also Medivolve owns a 30% stake in Glenco medical corp. They have 5 people working with an online store. So they must be making revenue https://www.glencomedical.com/store/. Then Medivolve have Investment in Dr. Anne-Claude Gingras (Mt. Sinai Hospital), Dr. Samira Mubareka and Dr. Rob Kozak (Sunnybrook Research Institute)